Vertos Medical is an interventional pain company committed to developing innovative, minimally invasive treatments for lumbar spinal stenosis (LSS). Mild®, its proprietary technology, is an image-guided outpatient procedure that removes a major root cause of LSS through an incision smaller than the size of baby aspirin and doesn’t require implants, general anesthesia, or stitches. The Mild Procedure has been clinically demonstrated to have a safety profile equivalent to epidural steroid injections with durability out to 5 years, and patients typically return to activities of daily living within 24 hours with no restrictions.* Mild is nationally covered by Medicare and has been performed on thousands of patients. To learn more, visit www.Vertosmed.com.
Privacy Policy: vertosmed.com/privacy-policy/
Terms of Use: vertosmed.com/terms-of-use/
Vertos is an equal employment opportunity workplace committed to pursuing and hiring a diverse workforce. We strive to grow our team with highly skilled people who share our culture and values. All qualified applicants will receive consideration for employment without regard to sex, age, color, race, religion, marital status, national origin, ancestry, sexual orientation, gender identity, physical & mental disability, medical condition, genetic information, veteran status, or any other basis protected by federal, state or local law.
*Clinical data: https://bit.ly/39GckQ6
LESspine™ is a medical technology development company for treating the musculoskeletal system with a special focus in spine devices and instruments leveraging physician collaborations and our Less Exposure Surgery (LES®) treatment philosophy invented by Founder and Professor, Dr. Kingsley R Chin, a Harvard-trained board-certified orthopedic spine surgeon.
LESspine Innovations is a KICVentures Group portfolio company focused on research and development.
For all LESspine jobs visit: http://www.kicventures.com/blog/careers/
SpineAlign Medical Inc. is an early-stage medical device company dedicated to improving patient outcomes through the development of innovative, minimally-invasive products to treat disorders of the spine.
SpineAlign Medical’s first technology is a nitinol implant designed to improve the treatment of vertebral compression fractures in the thoracic or lumbar spine. These fractures most frequently occur in patients suffering from osteoporosis. The VerteLift™ Implant is CE marked and is in commercial distribution in Europe. The VerteLift Implant is not yet available for sale in the United States; it is currently in an Investigational Device Exemption Trial (IDE Trial).
The dedicated SpineAlign Team is committed to advancing minimally invasive treatment of spinal disorders and is currently developing additional technologies to meet emerging clinical needs.